SBDS and neoplasm: In conclusion, our study as presented here demonstrates that SBDS is not only a potential biomarker or prognostic factor of human cancers, but also could be targeted for cancer therapy, as its knockdown triggers the ribosomal stress-p53 pathway to prevent tumor growth and progression.